Commercialization: Page
-
PharmaVoice Team/PharmaVoice
On the Calendar
April 2006 On the Calendar April 17-19 2006 World Health Care Congress Marriott Wardman Park Hotel, Washington, D.C. PharmaVOICE is exhibiting at this event. For more information, contact Tracey Fielding, World Congress, at 781-939-2555, e-mail [email protected], or visit worldcongress...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Patients, Not Just Physicians, Need Continuing Education
Patients, Not Just Physicians, Need Continuing Education A knowledgeable patient needs to become the norm, and effective education can improve the overall quality of his or her healthcare treatment. Trapezoid Healthcare Communications LLC Alan Toltzis, President ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Star Volunteer Sharon Callahan, president of Summit Grey, has been named as the 2006 HBA Star Volunteer by the Healthcare Businesswomen’s Association (HBA). Aside from leading the interactive agency, Ms. Callahan dedicates much of her time to HBA activities. She began her involvement in 1989 and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Measuring Online Success
Measuring Online Success Gary Mincieli, President Patrick Sosalski, Senior Online Business Analyst Internet marketers are projected to allocate billions of dollars this year to reach the healthcare consumer. These dollars will be divided among banner campaigns, search networks such as Goo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
CRM: Can it really be pulled off? Contributed by Ian Cross It’s official — all direct-to-consumer (DTC) ads now look the same. TV commercials have gone the way of concerned physicians depicted as animated characters who look like Pixar movie extras or the loving, older couples, who will never ret...
By Ian Cross • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies DataLabs Launches Products to Enhance e-CDM DataLabs has released DataLabs Clinical, a single data-management system that unifies the functionality of paper data entry (PDE) with the flexibility of electronic data capture (EDC). D...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Drugs in the real world There is an increasing need for more information about prescription drugs once they are approved and available to the larger marketplace. Phase IV studies have become important vehicles for postapproval risk-management and drug-safety assessment. Features The ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Damn the Torpedoes, Full Speed Ahead Recent calls from academic ivory towers to end pharmaceutical and device company collaboration with doctors and medical centers are stupefying and potentially dangerous. Stupefying because pharmaceutical companies are often a patient’s best ally against pain, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Birth of a New Market
Women want more than just birth control. They are looking for additional benefits from contraceptives to meet their individual needs. By Cynthia Borda A wide choice of contraceptive products has been introduced to the market in recent years, representing innovative new products and options in bir...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Postmarketing Studies
Timothy Pratt, Ph.D., Chief Marketing Officer and Principal Scientific Advisor of MedNet Solutions Inc., discusses how postmarketing research, just like everything else successful companies do, is all about marketing, and marketing is all about meeting customers’ needs. Properly constructed and e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Phase IV studies appear to be the hottest thing in clinical research. More and more companies are fulfilling their regulatory commitments, more CROs are benefitting from the outsourced programs, and physicians have additional avenues for bolstering their resumes. But what about the patients — you...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Market for Biochips in Clinical Research Expected to expand As biochip technology makes the transition from bench to bedside in the clinical-trial process, improved patient therapies will result, according to a recent report from Frost &...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Courting Resolution
By Kim Ribbink Product Litigation is Straining the Industry Product litigation has become an onerous fact of life for the pharmaceutical industry. Roughly 50 products are currently under active litigation in the United States, according to various industry sources. Legal experts say it’s not so m...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Hitting the Moving Target: Reaching Key Decision Makers to Avoid Therapeutic Substitution
Hitting the Moving Target: Reaching Key Decision Makers to Avoid Therapeutic Substitution The Media Mix Linda Ciccarelli Senior Media Director Gwen Canter Media Director Jasmine Robinson Assistant Media Director The right media mix directed toward influential targets should a...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Role of Independent Agencies
The Role of Independent Agencies Independent agencies need to harness unconventional thinking for every client challenge. The lack of bureaucracy and nimble structure can only be a strength if it leads to better ideas. The Agency Structure Agencies — large and small, independent and netwo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Winning Approach To New Business: To Pitch or Not to Pitch?
The Winning Approach To New Business: To Pitch or Not to Pitch? The Agency Process Steven Michaelson Founder/CEO Wishbone/ITP Inc. It is a common industry tenet that new business is the life blood of an agency. Unfortunately, it can also be the death of an agency. Developing a strong, consistent,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Building a Global Vision for Brands
Building a Global Vision for Brands Global Branding Richard T. Minoff President, Dorland Global Health Communications Dorland Global Corp. The convergence of markets and media across international lines provides rich opportunity for healthcare companies to achieve new levels of...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Times are Changing
Times are Changing By Daniel Limbach What a difference a year makes. While 2005 will be remembered by pharmaceutical companies as a year of great change, 2006 will be thought of as the year of changing strategies. any pharmaceutical companies that depend...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Steve Andrzejewski Eric J. Bruce Rick Kelly Dan McCall Robert Murphy Adriana Sax King Pharmaceuticals Hires and Promotes King, Bristol, Tenn., a vertically integrated branded pharmaceutical company, has appointed Steve Andrzejewski to chief commercial officer. His new responsibilities...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Drugs in the Real World
By Denise Myshko A greater regulatory focus on safety means companies are under pressure to provide more information about a prescription drug, as well as about the characteristics of patients, once a product becomes available to the larger marketplace. companies are being asked to provide inform...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Consumer Health Market Trends Show Continued Interest in E-Based Sources The population of consumers using the Internet as their primary learning channel for health information continued an upward trajectory in 2005, with 31.6 million consumers reporting that the Internet is their first stop when...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Pharmaceutical Consumerism and the Next Phase of Drug Promotion Contributed by Russell LaMontagne For the last decade, many have argued that direct-to-consumer (DTC) advertising is bad for consumers. At the end of the 1990s, when drug costs exceeded hospital costs for the first time, critics of t...
By Russell LaMontagne • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Stopping power seems to be harder to achieve these days with DTC print ads. Predictablity has become the woeful result of having to present legal mandatories, client “requests” for a bigger logo, oh — and not to forget — some kind of sell crammed in whatever space is left. The result is often a 5...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Drug Delivery: A Pipeline of Research and Market Opportunities
By Denise Myshko Delivery technologies will play an increasingly important role in the drug-development process as a means to improve the efficacy of a drug; make a drug safer, more effective, or convenient; extend its patent life; or differentiate it in the marketplace. In recent years, there ha...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Marketing is everything that a company does to reach and persuade prospects. The sales process is everything that a company does to close the sale and get a signed agreement or contract. Despite having objectives that would appear to be in sync, it’s not uncommon for a company to be unbalanced wh...
By Taren Grom • Jan. 2, 2008
Previous
